‌

US Patent 8044181 Antibodies to the PcrV antigen of

Patent 8044181 was granted and assigned to KaloBios Pharmaceuticals on October, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

KaloBios Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

80441810

Patent Inventor Names

Christopher R. Bebbington0

Mark Baer0

Kenneth Luehrsen0

Geoffrey T. Yarranton0

Date of Patent

October 25, 2011

Patent Application Number

123258060

Date Filed

December 1, 2008

Patent Primary Examiner

‌

Anne M. Gussow

Patent abstract

The current invention provides high-affinity antibodies to the Pseudomonas aeruginosa PcrV protein that have reduced immunogenicity when administered to treat Pseudomonas aeruginosa infections.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8044181 Antibodies to the PcrV antigen of

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API